Background: The predictors of recurrent colorectal adenoma have not been fully examined. This study aimed to evaluate the predictors of recurrent colorectal adenoma after initial screening colonoscopy with adenoma polypectomy. Methods: A retrospective cohort study was conducted at the Taipei Veterans General Hospital from 2003 to 2011. After screening, 356 patients who had undergone two consecutive colonoscopies with colorectal adenoma polypectomy at the initial colonoscopy were enrolled. The recurrence group was patients with recurrent colorectal adenoma at the second colonoscopy, whereas the nonrecurrence group was patients without recurrence. Anthropometric data, biochemical tests, metabolic comorbidities, and adenoma characteristics at initial colonoscopy were compared between the two groups. Cox proportional hazard regression analysis was conducted to identify the predictors of recurrent colorectal adenoma. Results: During a mean follow-up interval of 3.07 ± 1.42 years, 94 patients (26.4%) were in the recurrence group, 262 patients (73.6%) were in the nonrecurrence group. The recurrence group was older, had a wider waist circumference, higher levels of serum alanine aminotransferase (ALT) and triglyceride, a higher prevalence of smoking, nonalcoholic fatty liver disease, metabolic syndrome, and hypertension, and a higher occurrence of initial multiply-located adenomas when compared with the nonrecurrence group ( p < 0.05). Cox regression analysis showed that hypertension, smoking, higher ALT level (>40 IU/mL), and multiply-located adenomas were independent predictors for recurrent colorectal adenoma. The risk of recurrent adenoma increased when hypertension was combined with smoking, high ALT level, or multiply-located adenomas. Conclusion: Hypertension is an important predictor for recurrent colorectal adenoma after screening colonoscopy with polypectomy.
Introduction
Colorectal cancer (CRC) is one of the most common malignancies in the world. Although CRC's mortality in the West is declining, it appears to have a rapidly rising trend in Asia among both males and females. 1 According to a report by the Bureau of Health Promotion in Taiwan, CRC is the most common cancer in Taiwan, with an age-standardized incidence Conflicts of interest: The authors declare that there are no conflicts of interest related to the subject matter or materials discussed in this article.rate of 37.6 per 100,000 people in 2008. It also has the second highest total lifetime health expenditure among all malignancies because of its high incidence rate. 2, 3 Based on the concept of the adenoma-carcinoma sequence, colorectal adenoma is considered a precursor of CRC. It has been believed that screening for CRC can reduce mortality and morbidity by detecting cancer at an earlier, curable stage and by removing colorectal adenomas. 4e6 Colonoscopic removal of colorectal adenomas not only decreases incidence of CRC but also significantly reduces the risk of death from CRC, as compared with that in the general population. 4, 7 Therefore, several guidelines and consensus were established for clinical CRC screening and surveillance according to different stratified risks. 1, 6, 8 Current evidence supports the concept that patients who are obese, particularly those with abdominal obesity, 9 diabetes mellitus, or metabolic syndrome, are linked to insulin resistance, which plays an important role in development of CRC.
10e12 Similarly, colorectal adenoma has been closely associated with obesity, diabetes mellitus, metabolic syndrome, and insulin resistance in several studies. 13e15 The identification of risk patients has become important after colonoscopy screening in the general population and before surveillance in patients in whom adenoma has been previously detected. The current study attempted to clarify the predictors of recurrent adenoma after initial screening colonoscopy with adenoma polypectomy.
Methods

Patients
Asymptomatic patients who received two consecutive selfpaid health check-ups and colonoscopies with colorectal adenoma polypectomy at first colonoscopy at Taipei Veterans General Hospital, Taipei, Taiwan between January 1, 2003 and December 31, 2010 were enrolled. There were 2255 patients who received two consecutive check-up colonoscopies, and there were 446 with colorectal adenoma polypectomy at first colonoscopy. After excluding patients with a history of CRC, inflammatory bowel disease, nonadenomatous polyp, and long-term use of aspirin or nonsteroidal anti-inflammatory drugs, 356 eligible patients were enrolled. This study complied with the standards of the Declaration of Helsinki and current ethical guidelines. The hospital's Institutional Review Board approved the study (#2011-08-010IC).
Anthropometric and laboratory measurements
Detailed chart review including smoking, alcohol consumption, and medical and family history, were recorded. Anthropometric measurements (i.e., body height, body weight, waist circumference, and blood pressure) were taken by experienced nursing staff. Waist circumference was measured based on the modified National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) definition. 16, 17 The body mass index (BMI) was calculated as weight ( 18 or patients with hypertension and under antihypertension medication. Liver ultrasound examinations were performed using the Philips HD15 ultrasound system machine (Royal Philips Electronics, North Andover, MA, USA) by experienced radiologists. "Fatty liver" was considered if the contrast between the liver and parenchyma of the right kidney was increased, whereas nonalcoholic fatty liver disease (NAFLD) was diagnosed as the presence of fatty liver without viral (hepatitis B or hepatitis C), autoimmune or other liver diseases, or heavy alcohol consumption (>20 g/day). 3 All anthropometric and laboratory data, metabolic comorbidities, and the findings of screening colonoscopy were taken at the time of the first health check-up.
Colonoscopy
Colonoscopy was performed by experienced gastroenterologists and colorectal surgeons. The withdrawal time of colonoscopy was at least 6 minutes to minimize any chance of missing lesions. Detailed colonoscopy findings, including polyp size, number, and location and procedure of polypectomy were recorded. A lesion above the splenic flexure was defined as proximal and one in the left colon including the sigmoid and rectum was defined as distal adenoma. 3 Advanced adenoma was defined as adenoma size >10 mm, with villous or tubule-villous architecture, or with high-grade dysplasia. 3 Multiply-located adenomas was defined as at least two adenomas located at different sites (including ascending colon, transverse colon, descending colon, and sigmoid/rectum). Experienced pathologists confirmed the diagnosis of adenoma by histological examination after colonoscopic polypectomy. Among the 356 eligible patients, 94 patients were classified into the recurrence group (adenoma detected at the second colonoscopy after initial screening colonoscopy with adenoma polypectomy), whereas 262 patients were classified into the nonrecurrence group (absence of adenoma at the second colonoscopy after initial screening colonoscopy with adenoma polypectomy). The adenoma detection rate was 19.8% for the first-time colonoscopy and 26.4% for the second-time colonoscopy.
Statistical analysis
All statistical analyses were performed using SPSS software (version 17.0; SPSS Inc., Chicago, IL, USA). Demographic data were expressed as frequency (percentage) or as mean ± standard deviation. Continuous variables were compared using the Student t test, whereas categorical data were compared by Chisquare test and Yates correction or Fisher's exact test, as appropriate. Multivariate regression analysis was conducted using Cox proportional hazard regression analysis to identify the predictors of recurrent adenoma, including age, sex, smoking, anthropometric data, biochemical tests, metabolic comorbidities, and adenoma characteristics. A two-sided p < 0.05 was considered statistically significant.
Results
Patient characteristics
Among the 356 enrolled patients, 262 (73.6%) were male and 94 (26.4%) female, and the mean age was 55.1 ± 9.0 years old. Eighty-three (23.3%) patients had a history of smoking. Eighty-two (23.0%) patients had hypertension, including 55 patients taking antihypertension medication, thirty-nine (11%) patients had diabetes, 92 (25.8%) patients had received a diagnosis of metabolic syndrome, and 150 (42.1%) patients had NAFLD. The mean BMI was 24.53 ± 3.09 kg/m 2 . During the initial screening colonoscopy with adenoma occurrence and polypectomy, the most common locations of adenomas were the sigmoid colon (n ¼ 125, 35.1%), followed by the rectum (n ¼ 90, 25.3%) and ascending colon (n ¼ 88, 24.7%). Sixty-four patients (18.0%) had advanced adenomas, 125 (35.1%) patients had proximal adenoma, and 60 (16.9%) patients had multiply-located adenomas.
Comparison between nonrecurrence group and recurrence group
During a mean follow-up interval of 3.07 ± 1.42 years between the two consecutive colonoscopic examinations, all enrolled patients were divided into a nonrecurrence group (n ¼ 262, 73.6%) and recurrence group (n ¼ 94, 26.4%).
Comparison between the two groups showed that the recurrence group was older, had a wider waist circumference, higher serum ALT, GGT, and triglyceride, and higher prevalence of smoking, NAFLD, metabolic syndrome, and hypertension than the nonrecurrence group ( p < 0.05, Table 1 ). The recurrence group also had a higher occurrence of initial multiply-located adenomas. However, there was no significant difference in sex, BMI, diabetes, serum total cholesterol, LDL, HDL, the occurrence of proximal adenoma, and advanced adenoma between the two groups ( Table 1) .
Independent predictors for colorectal adenoma
Cox proportional hazard regression model analyses for predictors of recurrent adenoma are shown in Table 2 . Smoking, hypertension, ALT >40 IU/mL, and multiply-located adenomas but not metabolic syndrome were independent predictors for developing recurrent colorectal adenoma after initial colonoscopy with adenoma polypectomy. were independent predictors for recurrent colorectal adenoma after Cox proportional hazard regression analyses.
Risk of recurrent colorectal adenoma by the presence of hypertension with other predictors
The risk of recurrent adenoma in hypertension patients with other predictors are shown in Table 3 . By adjusting for other confounding factors, the HR of recurrent adenoma increased when hypertension was associated with smoking, high ALT, and multiply-located adenomas, respectively (Table 3 ).
Discussion
About 20e50% of patients with colorectal adenomas will experience recurrence in a 3-to 5-year period.
19e21 However, only a limited number of studies have discussed the risk factors or predictors of recurrent colorectal adenomas. 22e24 In the current study, we found that hypertension, smoking, higher ALT (>40 IU/mL), and multiply-located adenomas were independent predictors for developing recurrent colorectal adenoma after initial colonoscopy with adenoma polypectomy. Also, the risk of recurrent adenoma increased when hypertension coexisted with smoking, high ALT level (>40 IU/mL), or multiply-located adenomas, respectively.
Hypertension was found to be a predictor for colorectal adenoma formation in previous studies, 3, 25 but other studies reported conflicting findings 26, 27 and some did not include hypertension as a predictor for analysis. 28, 29 However, studies that evaluated the risk factors or predictors for recurrent colorectal adenoma did not pay any attention to hypertension as a potential predictor. 22, 23 The finding in this study that hypertension rather than metabolic syndrome was a key predictor for recurrent colorectal adenoma should remind all researchers to pay attention to this important factor in evaluating the predictors of primary or recurrent colorectal adenoma. However, the possible mechanisms or interactions between hypertension and recurrent colorectal adenoma remain uncertain and need further clarification. Whether there is a dose-response relationship between BP and recurrence of adenoma is an interesting question. Because 55 of the 82 hypertension patients in this study had taken antihypertension drugs, the baseline blood pressure values without taking medication could not be obtained exactly in two-thirds of the hypertension patients.
Therefore, we did not analyze whether a dose-response relationship existed between blood pressure level and recurrence of adenoma.
Smoking has been a known risk factor of recurrent colorectal adenomas, 24, 30 and exposure to smoking significantly increases the prevalence of distal, tubular, larger, and multiple adenomas. 29 Several previous studies also supported that smoking increases the size of colorectal polyps. 31, 32 However, we did not observe that smoking was correlated to adenoma number or size (data not shown). Previous studies have also shown that smoking is an important risk factor of primary colorectal adenoma after an initial negative screening colonoscopy. 3 Therefore, smoking is a convenient and important indicator for clinicians to assess primary or recurrent colorectal adenomas in their daily practice.
Metabolic syndrome is composed of a cluster of cardiovascular risk factors including insulin resistance, dyslipidemia, central obesity, and prehypertension. Several previous studies have shown that metabolic syndrome is associated with increased risk of colorectal adenoma, 13, 25, 27, 33 but others do not support this theory. 34, 35 Evidence concerning the relationship between recurrent colorectal adenoma and metabolic syndrome is relatively limited. Our study demonstrated that metabolic syndrome was not a predictor of recurrent colorectal adenoma by multivariate Cox regression analysis.
According to the updated guidelines for colonoscopy surveillance after screening and polypectomy by the US MultiSociety Task Force on Colorectal Cancer, 8 the recommended surveillance interval for multiply-located adenoma and advanced adenoma is 3 years. About one-third of the patients in our study had multiply-located or advanced adenoma at the initial colonoscopy. The mean follow-up interval in this study was 3.07 years between the two consecutive colonoscopic examinations. Only 26.4% of patients had recurrent adenoma, and none of them developed CRC. The updated guideline is in line with our study findings and general clinical practice.
Limitations
The current study has several limitations that are worth noting. First, it was a retrospective study with observations based on patients who came in for a health check-up. Certain selection biases indeed exist therefore caution must be exercised in extrapolating the results. Second, the socioeconomic status of our study group was relative higher in Taiwan society, and this may be another confounding factor in data analysis. Third, a missed polyp is inevitable for each experienced colonoscopist during examination and decreases the accuracy of this kind of study. However, all screening or surveillance studies of colon adenoma-carcinoma have the same inevitable problems. Finally, though patients taking long-term aspirin or nonsteroidal anti-inflammatory drugs were excluded, patients taking statins, which might be chemoprotective for colorectal adenoma, were not excluded.
In conclusion, after adjusting for age, sex, anthropometric data, biochemical tests, metabolic comorbidities, and adenoma characteristics at initial colonoscopy by Cox regression analysis, hypertension was an important predictor for recurrent colorectal adenoma after screening colonoscopy with adenoma polypectomy.
